Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study.
Pasquale AragonaJose M Benítez-Del-CastilloMinas T CoroneoSubhanjan MukherjiJacqueline TanEvelien VandewalleAlgis Jonas VingrysHaixia LiuCindy Carlisle-WilcoxJoseph VehigePeter A SimmonsPublished in: Clinical ophthalmology (Auckland, N.Z.) (2020)
The new CMC-HA formulation was effective and well tolerated, and demonstrates a greater potential for symptom relief compared with CMC. These data support implementation of this formula for the management of dry eye patients.
Keyphrases
- hyaluronic acid
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- primary care
- healthcare
- peritoneal dialysis
- drug delivery
- prognostic factors
- electronic health record
- clinical trial
- big data
- cross sectional
- risk assessment
- machine learning
- patient reported outcomes
- climate change
- preterm birth